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To celebrate the 60th anniversary of SCIENCE CHINA, six 
research groups of overseas and domestic Chinese immu-
nologists published a series of review articles (SCIENCE 
CHINA Life Sciences, 2010, 53(2): 157–158), which high-
lighted recent advances and their contributions to immu-
nology.  
Wang YaYa in Prof. Cheng GenHong’s group, who dis-
covered the function of TNF receptor-associated factor 
(TRAF) and other signal molecules in Toll-like receptor 
(TLR) mediated signaling pathway and innate immunity [1], 
reviewed TRAF-mediated regulation of immune and in-
flammatory responses [2]. TRAF family consists of six 
mammalian members (TRAF1, TRAF2, TRAF3, TRAF4, 
TRAF5, and TRAF6) and participates in signal transduction 
of a large number of receptor families such as TNF receptor 
family (TNFR) and TLR-interleukin-1 receptor (TLR-IL-1R) 
family. Upon receptor-mediated activation, TRAFs are di-
rectly or indirectly recruited to the intracellular domains of 
these receptors and subsequently combine with other sig-
naling molecules to activate the inhibitor of IB kinase 
(IKK) complex, TRAF family member-associated NF-κB 
activator (TANK)-binding kinase 1 (TBK1) and the induci-
ble IκB kinase (IKK-i), ultimately leading to activation of 
transcription factors, such as NF-B, interferon-regulatory 
factor (IRF), to induce immune or inflammatory responses. 
In the past few years, immunologists have demonstrated the 
central role of TRAFs in inflammation, innate immunity, 
and regulation of NF-B pathway, as well as type 1 inter-
feron expression. However, many aspects on TRAFs func-
tion and molecular mechanism remain to be further clari-
fied. 
Prof. Liu Yang et al., who provided the first experi-
mental evidence that pathogen recognition by the innate 
immune system turns on the adaptive immune system [3], 
summarized how the immune system controls the balance 
between recognizing pathogen-associated molecular pat-
terns (PAMPs) and danger-associated molecular patterns 
(DAMPs) [4]. They discovered a novel pathway mediated 
by CD24 and its receptor, Siglec G, in mouse or Siglec 10 
in human, which deepens our understanding on how host 
establishes sterilizing immunity to most pathogens and 
avoids fatal damage in response to aseptic tissue injury. The 
CD24-mediated pathway suppresses host response to 
DAMPs, but not to PAMPs, therefore, allowing the host to 
distinguish PAMPs from DAMPs. Blocking this pathway 
results in a devastating systemic inflammatory response when 
necrosis occurs in mouse model. Therefore, CD24/Siglec 10 
pathway enables a cross-reactive pattern recognition to ini-
tiate immunity against pathogens without significant im-
mune-mediated self-destruction in case of tissue injury. 
However, the cross-talk between CD24 receptor-mediated 
pathway and TLR signaling is remained to be further studied. 
Tang Fei in Prof. Liu YongJun’s group, who discovered 
plasmacytoid dendritic cells (pDCs) about 10 years ago 
[5,6], presented a review on the role of pDCs in anti-viral 
immunity and autoimmunity [7]. The pDCs are capable to 
express large amount of type I interferons (IFNs) in re-
sponse to viral infection, since they express TLR7 and 
TLR9, which recognize viral nucleic acids in the endosomal 
compartment. The pDCs-expressed type I IFNs not only 
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suppress viral replication directly but also play an important 
role in the regulation of innate and adaptive immunity. Ab-
errant activation of pDCs by self nucleic acids and the sub-
sequent production of type I IFNs are also observed in some 
autoimmune diseases. So that, pDC could be an attractive 
therapeutic target for the vial infection and autoimmune 
diseases. Whereas, Tang et al. pointed out in this review 
article that specific and detailed pathway for pDC develop-
ment, and how to develop a safe and effective immu-
no-therapeutics for viral infectious and autoimmune diseas-
es need to be further investigated.  
Wang ShengDian in Prof. Chen LiePing’s group, who 
discovered various co-stimulatory molecules in T cell acti-
vation [8], contributed a review on the structural immunol-
ogy of co-stimulatory and co-inhibitory molecules [9]. 
Co-stimulatory signaling pathways in T cells play a central 
role in regulating immune responses. Targeting these path-
ways represents one of the most promising approaches for 
the development of immuno-therapeutics. The structure of 
costimulatory molecule reveals invaluable mechanistic in-
sights underlying costimulatory receptor/ligand specificity, 
affinity, oligomeric state, and valency, and provides an ex-
traordinary opportunity for the development of immuno-
therapy for T cell co-stimulatory pathway-related disorders. 
Prof. Tang Hong and Fu YangXin introduced their recent 
finding [10] on T cells in dampening innate inflammatory 
responses [11]. This finding suggests that T cells of adap-
tive immunity regulate innate responses, therefore, shed 
new light on the evolution and interaction between innate 
and adaptive immunity. Further understanding of the un-
derlying mechanisms will help us to make better clinical 
diagnosis and treatment for various infectious and inflam-
matory diseases. 
Finally, Zhang LiGuo in Prof. Chen JianZhu and Su 
LiShan’s group contributed the last article on establishment 
of a new generation of humanized mouse for studying hu-
man immunology and HIV-1 immuno-pathogenesis in vivo 
[12]. They described the criteria of robust animal model for 
hypothesis testing and mechanistic research in human im-
munology and immunopathology should be met, and sum-
marized the current understanding of HIV-1 immunopatho-
genesis in patients and in SIV-infected primate models as 
well as the recent progress in the development of human-
ized mouse model, especially the immunodeficient mouse 
that carries a defective gammaC gene. These mouse models 
lack NK, T and B cells, which are crucial for the in vivo 
study of human immunology and stem cell biology in tissue 
development and functional expression. 
Immunology has become an integral component of med-
ical science, deepening our understanding for the patho-
physiology of human diseases, and has contributed greatly 
to the development of therapeutics for infection, autoim-
mune diseases, allergy and cancer. I believe that these re-
views above are valuable for both Chinese communities of 
immunology and medicine.   
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